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Abstract
Background: Terminally differentiated (TD) cells permanently exit the mitotic cycle while acquiring specialized
characteristics. Although TD cells can be forced to reenter the cell cycle by different means, they cannot be made to
stably proliferate, as attempts to induce their replication constantly result in cell death or indefinite growth arrest. There is
currently no biological explanation for this failure.
Principal Findings: Here we show that TD mouse myotubes, reactivated by depletion of the p21 and p27 cell cycle
inhibitors, are unable to complete DNA replication and sustain heavy DNA damage, which triggers apoptosis or results in
mitotic catastrophe. In striking contrast, quiescent, non-TD fibroblasts and myoblasts, reactivated in the same way, fully
replicate their DNA, do not suffer DNA damage, and proliferate even in the absence of growth factors. Similar results are
obtained when myotubes and fibroblasts are reactivated by forced expression of E1A or cyclin D1 and cdk4.
Conclusions: We conclude that the inability of myotubes to complete DNA replication must be ascribed to peculiar features
inherent in their TD state, rather than to the reactivation method. On reviewing the literature concerning reactivation of
other TD cell types, we propose that similar mechanisms underlie the general inability of all kinds of TD cells to proliferate in
response to otherwise mitogenic stimuli. These results define an unexpected basis for the well known incompetence of
mammalian postmitotic cells to proliferate. Furthermore, this trait might contribute to explain the inability of these cells to
play a role in tissue repair, unlike their counterparts in extensively regenerating species.
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Introduction
Our persistent inability to induce proliferation of terminally
differentiated (TD) cells has no definite biological basis. Though
perhaps superseded by more urgent questions in recent years, this
problem remains unsolved.
In vertebrate species capable of extensive regeneration, such as
salamanders, many cell types homologous to mammalian TD cells
are not postmitotic and can proliferate in response to injuries to
reconstitute organ integrity [1,2]. Determining why our TD cells
are unable to accomplish the same feat would shed light on the
reasons for our poor regenerating competence.
Terminal differentiation is defined by the permanent exit from
the cell cycle that takes place in the course of acquiring functional
specialization. TD cells, once thought to be utterly incapable of
reentering the cell cycle, have been shown to possess a largely
functional proliferation machinery that can be reactivated by a
number of experimental manipulations. Various types of TD cells
have been reactivated by exploiting oncogenic viruses such as
polyomavirus [3], SV40 [4,5,6], adenovirus [7], or papillomavirus
[8]. Viral oncogenes are not unique in their ability to reactivate
TD cells. Indeed, TD skeletal muscle cells (myotubes) can be
induced to reenter the cell cycle by overexpressing cyclin D1 and
cdk4/6 [9], knocking down cyclin-dependent kinase inhibitor(s)
(CKIs) [10], or expressing the Twist bHLH protein [11]. TD,
adult cardiomyocytes can be reactivated by forcibly expressing
E2F1 [12], a variant cyclin D1 bearing a nuclear localization
signal along with cdk4 [13], or the Notch2 intracellular domain
[14], or by suppressing specific CKIs (F. Martelli, personal
communication). Neurons synthesize DNA upon ectopic expres-
sion of E2F factors [15] and inner-ear hair cells do so following
expression of the HPV E7 oncoprotein [16]. Most of these
manipulations attain TD cell reactivation, at least in part, by
switching on the G1 cyclin/cdk-pRb-E2F axis [9,10,12,17,18], an
exception being possibly represented by Twist, whose mechanism
of action is still under investigation.
Despite the successes in reactivating TD cells and elucidating
the mechanisms thereof, inducing proliferation of TD cells
remains unfeasible. To the best of our knowledge, no means to
induce stable proliferation of any TD cell type has been reported,
a few claims to the contrary notwithstanding. Some TD cell types
can indeed attempt or undergo cell division upon forced reentry
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adipocytes [9], and inner-ear hair cells [16]. However, full
divisions are generally not frequent and the newly formed cells
do not survive for long. Not all reports on TD cell reactivation
spell out clearly the eventual fate of the cells themselves. When
such fate is described, depending on the TD cell type subjected to
reactivation and the means used to induce it, two outcomes are
possible. In most cases, the reactivated cells undergo immediate or
delayed cell death. In some instances, however, the cells arrest
indefinitely in the G2 phase of the first cell cycle. Examples of the
first type are myotubes reactivated by the adenoviral oncogene
E1A [9] or the SV40 Large T antigen (TAg) [20], or by
suppression of CKIs [10] and neurons forced into the cell cycle by
expression of TAg [6]. Inner-ear hair cells reactivated by HPV E7
expression or by the lack of CKIs also die more or less promptly,
before or after undergoing mitosis [16].
G2 phase arrest occurs in myotubes reactivated by overexpres-
sion of cyclin D and cdk4/6 and cardiomyocytes triggered to
reenter the cell cycle by expression of E1A or E2F1 [12] or by
Notch signaling [14].
In an attempt to identify the reasons for the general failure of
TD cells to proliferate, we have explored the consequences of
acutely suppressing specific CKIs in myotubes. We found that TD
myotubes reactivated by this and other means cannot complete
DNA replication, incur lethal DNA damage at the very beginning
of S phase, and die by apoptosis. Since non-TD cells reactivated in
the same ways suffer no detectable harm, we conclude that
reactivation brings about incomplete DNA replication and DNA
damage as the results of a peculiar feature of myotubes and—we
propose—of most TD cells.
Results
Cell cycle reactivation causes mitotic aberrations and
death in TD myotubes but not in quiescent fibroblasts
To study in depth the consequences of cell cycle reactivation in
TD vs. non-TD cells, we subjected TD myotubes derived from
mouse satellite cells (MSC) and serum-deprived, quiescent C3H-
10T1/2 mouse fibroblasts to RNA interference (RNAi) for p21
and p27 (Fig. 1A). As previously reported, interference with
relevant CKIs induces reentry into the cell cycle of quiescent,
senescent, and TD cells alike [10]. Fig. 1B shows that 37% of the
fibroblasts and 62% of the myotubes incorporated 5-bromo-29-
deoxyuridine (BrdU) in these conditions. However, the eventual
fates of the two cell types diverge strikingly. While the fibroblasts,
as already shown, proliferate in the following days in the
continuing absence of serum [10], the reactivated myotubes die
within 3 days (Fig. 1C).
Microscopic observation showed that the mitoses occurring in
the reactivated myotubes are invariably extremely aberrant. While
some mitoses display a large number of anomalies such as
Figure 1. BrdU incorporation and death in cells reactivated by
CKI KD. (A) quiescent C3H-10T1/2 and myotubes were transfected with
the indicated siRNAs. The indicated proteins were analyzed by western
blotting 48 or 20 hours later, respectively. b-tubulin is a loading control.
(B) Serum-starved, quiescent C3H-10T1/2 fibroblasts and MSC-derived
myotubes were treated as indicated and incubated with BrdU for the
next 44 hours. BrdU incorporation was detected by indirect immuno-
fluorescence. (C) Myotubes were transfected with a control siRNA (to
GFP) or siRNAs to p21 and p27. The number of BrdU-positive myotubes
(BrdU, myosin double-positive cells) was counted in 10 random, low-
power microscopic fields at the indicated times post-transfection. Ctr =
control.
doi:10.1371/journal.pone.0011559.g001
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tion, most others show widely scattered and/or pulverized
chromosomes. In addition, myotubes surviving the mitotic phase
show an often extreme degree of micronucleation, the result of
nuclear membrane reassembly around isolated chromosome
fragments (Fig. 2A). On the contrary, quiescent fibroblasts
reactivated by the same means undergo morphologically normal
mitoses (Fig. 2B).
Differentiated muscle fibers and myotubes lack detectable
centrosomes [21] and have atypical microtubule organizing
centers at best [22]. Thus, it is conceivable that myotubes forced
to reenter the cell cycle might form dysfunctional mitotic spindles,
justifying at least in part the mitotic aberrations we observed. To
determine whether reactivated myotubes possess centrosomes and
can organize mitotic spindles, we stained myotubes subjected to
p21 and p27 knockdown (KD) with antibodies to c- and b-tubulin.
Supplementary material Fig. S1A shows that centrosomes are
readily stained by the c-tubulin antibody in proliferating MSC. In
undisturbed myotubes, the centrosomes are undetectable (data not
shown), consistent with previous reports [21]. However, reactivat-
ed myotubes promptly regenerated centrosomes, which were
positioned in the proximity of nuclei (supplementary material Fig.
S1A). In addition, the reactivated myotubes formed mitotic
spindles that, although often anomalous in shape, are clearly
recognizable as such (supplementary material Fig. S1B). Thus,
neither the absence of centrosomes nor the lack of mitotic spindles
is the likely cause of the deep mitotic anomalies. It should be noted
that similar mitotic aberrations are routinely observed in TD,
mononucleated muscle cells (myocytes) reactivated by CKI KD
(data not shown). Hence, the abnormal mitoses cannot be ascribed
to the presence of multiple nuclei in the myotube cytoplasm.
Reactivated myotubes, but not quiescent cells, suffer
heavy DNA damage
The observation of innumerable breaks in the mitotic
chromosomes of reactivated myotubes implies the presence of
very high levels of DNA damage in the preceding interphase. To
confirm this point, we stained p21/p27 KD cells with an antibody
to Ser
139-phosphorylated histone H2AX (c-H2AX), a marker of
double-strand DNA breaks. Fig. 3A,B illustrates that, while
myotubes transfected with control siRNA showed only basal c-
H2AX staining, 100% of the BrdU-positive, reactivated muscle
cells displayed an unusually intense staining for the marker. The
staining was peculiar not only with regard to its intensity, but also
to its pattern. Indeed, while the typical c-H2AX staining pattern is
represented by discrete nuclear foci [23,24], corresponding to
individual sites of damage, our myotubes displayed a confluent,
almost homogeneous c-H2AX distribution, suggesting the pres-
ence of very numerous DNA breaks. Conversely, serum-starved,
quiescent C3H-10T1/2 fibroblasts, also reactivated by p21/p27
RNAi, showed no increase in c-H2AX staining over the controls
(Fig. 3A,B). It should be noted that, as previously reported [25],
mitogen-mediated cell cycle reactivation (10% FBS for C3H-
10T1/2 cells, Fig. 3B) induces a physiological increase in H2AX
phosphorylation.
Notably, myotubes subjected to interference with either p21 or
p27 alone showed neither DNA synthesis nor increased c-H2AX
staining (supplementary material Fig. S2). This evidence shows
that ablation of each CKI per se does not bring about DNA
damage and indicates that such damage is strictly connected with
DNA replication which, in this system, requires double, p21/p27
KD.
A more direct way to assess DNA damage is the comet assay
[26], where agarose-embedded nuclei are stained with ethidium
bromide and subjected to electrophoresis to visualize DNA
fragments that migrate away from intact DNA. Using this assay,
we analyzed TD myotubes and quiescent fibroblasts transfected
with p21/p27 siRNAs, control siRNA, or mock transfected.
Reactivated myotubes displayed a high increase in DNA
fragmentation, as expressed by the tail-moment parameter (see
Materials and Methods), over control-transfected or unperturbed
myotubes (Fig. 3C). In contrast, no significant tail moment
increase was detected in fibroblasts after p21/p27 KD.
Altogether, these results show that reactivation causes heavy
DNA damage in TD myotubes, but not in similarly treated
quiescent fibroblasts. In turn, this implies that neither CKI
suppression nor the ensuing cell cycle reactivation per se harms
DNA, but that the observed damage must be rooted in the
peculiar properties of TD myotubes.
DNA synthesis in reactivated myotubes is incomplete
As described above, the chromosomal breaks observed in
mitotic myotubes and the ensuing micronucleation strongly
indicated the presence of DNA breaks. Another morphological
characteristic of these mitoses, namely DNA bridges, suggested
that DNA synthesis might be incomplete. Indeed, the BrdU
staining pattern of myotube nuclei was irregular, even after very
long BrdU labeling, suggesting that not all DNA regions are
entirely duplicated (Fig. 4A). In contrast, quiescent C3H-10T1/2
fibroblasts and C2Q16 myoblasts reactivated by p21/p27 RNAi
showed the expected homogeneous BrdU staining pattern
(Fig. 4A).
To explore the completeness of DNA replication in myotubes,
myoblasts, and fibroblasts reactivated as above, their nuclei were
isolated and analyzed by cytofluorimetry. Fig. 4B shows that the
majority of the reactivated myotube nuclei never reached 4n DNA
content, while fibroblasts and myoblasts readily did so.
Further, striking evidence of incomplete DNA synthesis in
reactivated myotubes came from the observation that a significant
fraction of their mitotic chromosomes are only partially substituted
with BrdU (Fig. 4C), as illustrated by the much smaller area
stained by BrdU antibodies, compared with that highlighted by
Hoechst 33258. Once again, such partial BrdU incorporation was
never observed in reactivated fibroblasts (Fig. 4C).
These results allow us to conclude that DNA replication is
incomplete in reactivated myotubes and that such partial
duplication is specific to TD myotubes and does not take place
in similarly reactivated non-TD cells. In addition, the occurrence
of nuclei undergoing mitosis in the face of incomplete DNA
replication implies a deep impairment of the G2 checkpoint.
Partial DNA replication might stem from defective reactivation
of the cell cycle apparatus in TD myotubes. Although past
investigations have shown that the cell cycle machinery can be
reactivated in TD cells, much as it is in reversibly quiescent ones
[17,27], subtle functional anomalies might have escaped detection.
We reasoned that, since aberrant DNA duplication is so
prominent in TD cells, any such anomalies would be likely to
directly involve components of the DNA replication apparatus or
indirectly impinge on them. Thus, we investigated the expression
of a number of factors involved in DNA replication in the
reactivated myotubes. Np95 and cdc6 were found to be correctly
reexpressed in these cells, at levels comparable to those of
proliferating MSC, while cdc7 levels were shown to be
independent of the replicative status of the cells (supplementary
material Fig. S3). Mcm2, PCNA, and Ligase I were also properly
expressed and associated with chromatin (supplementary material
Fig. S3). In short, we were unable to reveal any TD cell-specific
defects in the replication machinery. One possible interpretation of
S Phase in Postmitotic Cells
PLoS ONE | www.plosone.org 3 July 2010 | Volume 5 | Issue 7 | e11559Figure 2. Aberrant mitoses in CKI KD-reactivated myotubes but not in fibroblasts. (A) MSC-derived myotubes were transfected with
siRNAs to p21 and p27. The cells were fixed and stained 46 hours later. Bar =25 mm. (B) Serum-starved, quiescent C3H-10T1/2 cells were transfected
with siRNA to p21 and p27 and kept in medium containing 0.1% FBS. The cells were fixed and stained 44 hours later. Bar =12.5 mm.
doi:10.1371/journal.pone.0011559.g002
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PLoS ONE | www.plosone.org 4 July 2010 | Volume 5 | Issue 7 | e11559Figure 3. DNA damage in myotubes but not in fibroblasts reactivated by CKI KD. (A) MSC-derived myotubes and quiescent C3H-10T1/2
fibroblasts were transfected with the indicated siRNAs and stained 30 hours later. Bar =25 mm. The insets show magnifications of the area
surrounded by a small, white square in the top left panel. (B) MSC-derived myotubes and quiescent C3H-10T1/2 fibroblasts were treated as indicated
and double-stained for BrdU and c-H2AX 48 hours later. The percentages of BrdU- and c-H2AX-positive nuclei are shown. At least 100 nuclei per
treatment were scored. (C) MSC-derived myotubes and quiescent C3H-10T1/2 fibroblasts were mock-treated or transfected with the indicated siRNAs
and harvested 46 hours later. The cells were then embedded in agarose on microscope slides and lysed. The resulting free nuclei were subjected to
electrophoresis, stained with ethidium bromide, photographed, and morphometrically evaluated. The histograms reflect the average tail moment of
at least 50 comets per treatment. Cluster analysis and chi-square test showed the differences between histograms connected by brackets to be
significant with p,0.001. No other differences are significant. The microfotographs show examples of comets derived from myotube nuclei treated as
indicated. Ctr = control; siCtr = control, irrelevant siRNA; sip21+p27= mixture of equal amounts of siRNAs to p21 and p27.
doi:10.1371/journal.pone.0011559.g003
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be structural (e.g., impervious chromatin structure), rather than
functional.
Reactivated myotubes undergo apoptosis
As already described (Fig. 1), myotubes quickly die following cell
cycle reactivation. To determine whether they die by apoptosis, we
assessed cleavage-mediated activation of several molecules that
regulate and effect apoptosis. As shown in Fig. 5A, caspase 3,
caspase 9, and PARP-1 are all cleaved in a time-dependent fashion
in reactivated myotubes, but not in control-transfected cells.
To delay cell death, we used a recombinant adenovirus to
express the antiapoptotic gene Bcl-2 in MSC-derived myotubes.
Bcl-2 expression did allow the reactivated myotubes to conserve a
healthy morphology and survive much longer than those infected
with a control adenovirus (not shown). Fig. 5B shows that Bcl-2
expression did not appreciably affect the proportion of myotubes
undergoing DNA synthesis, but did allow a much higher
percentage of them to enter mitosis, in a dose-dependent fashion.
However, the mitoses of Bcl-2- and control-infected myotubes
were not morphologically different, showing that suppression of
apotosis does not relieve DNA damage.
Altogether, these results show that the reactivated myotubes die
by apoptosis and that cell death is triggered early enough as to
compete with entry into mitosis. Indeed, delaying programmed
cell death allows a large fraction of myotubes that would otherwise
die in the course of an unsuccessful S phase to reach mitosis.
DNA damage is generated very early during S phase and
is strictly associated with DNA replication
We wished to determine when DNA damage is engendered
during the cell cycle in reactivated myotubes. For this purpose, c-
H2AX was analyzed in MSC-derived myotubes at various time
points after p21/p27 siRNA transfection. Fig. 6A shows that c-
H2AX is already increased 20 hours after transfection, when only
5% of the myotubes have begun to synthesize DNA.
To further dissect the cell cycle and the timing of DNA damage
in reactivated TD muscle cells, we knocked down, along with p21
and p27, the D3, E1, or A2 cyclin. Fig. 6B shows that in this
setting DNA synthesis, as already reported for C2C12 myotubes,
critically depends on cyclin D3. In contrast, KD of either cyclin E1
or cyclin A2 only reduced the percentage of myotubes undergoing
DNA synthesis. Interestingly, the amount of DNA damage, as
estimated from c-H2AX levels, paralleled the number of myotubes
Figure 4. Incomplete DNA replication in myotubes but not fibroblasts reactivated by CKI KD. (A) MSC-derived myotubes and quiescent
C2Q16 myoblasts and C3H-10T1/2 fibroblasts were transfected with siRNAs to p21 and p27 and continuously incubated with BrdU until fixation,
44 hours later. BrdU was detected by indirect immunofluorescence and nuclei were counterstained with Hoechst 33258. Arrowheads point at some
incompletely, unevenly BrdU-substituted nuclei. Bar =12.5 mm. (B) C2Q16 myotubes and quiescent C2Q16 myoblasts and C3H-10T1/2 fibroblasts
were transfected with siRNAs to p21 and p27, stained with propidium iodide, and analyzed by cytofluorimetry at the indicated time points. (C) MSC-
derived myotubes and fibroblasts were treated and stained exactly as in (A). Mitotic figures were photographed. Bar =25 mm.
doi:10.1371/journal.pone.0011559.g004
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arising in reactivated myotubes is strictly associated with DNA
synthesis.
Since DNA damage occurs so early upon entry into S phase
(Fig. 6A), conceivably it might even shortly precede it. To try and
clarify this point, we used myotubes derived from Rb conditional
knockout (RbLox) MSC. As previously described [27], when the
Rb gene is acutely deleted through Cre recombinase expression,
these myotubes activate a variety of molecular events that usually
precede and associate with transition into S phase, including
transcription of E2F target genes, increases in cyclin-E and –A
associated kinase activities, enhanced expression of PCNA, DNA
ligase I, RPA, and MCM2. However, though poised to undergo
DNA duplication, these myotubes do not synthesize DNA. Fig. 6C
shows that Rb-LoxP myotubes expressed Ki67 in response to both
p21/p27 KD and Cre-mediated Rb KD. However, only the
former treatment brought about an increase in c-H2AX. Exactly
as reported in Fig. 3, 100% of the myotubes reactivated by p21/
p27 KD (n$100) were stained heavily for c-H2AX, while all of the
Ad-Cre-infected controls showed only background staining
(Fig. 6C). Thus, these experiments strongly indicate that DNA
damage depends on DNA synthesis, rather than any preceding
events.
DNA damage follows DNA synthesis in myotubes,
irrespective of the cell cycle reactivation mechanism
Conceivably, the DNA damage observed in reactivated
myotubes might be linked to the specific means used to trigger
cell cycle reentry. To exclude this possibility, we reactivated both
myotubes and quiescent fibroblasts by infection with the mutant
adenovirus, dl520 [17], or expression of cyclin D1 and cdk4 [9].
As shown in Fig. 7, myotubes reactivated in either way displayed
strong increases in c-H2AX levels, while fibroblasts brought into
the cell cycle by the same means did not.
Thus, we conclude that TD myotubes possess intrinsic features
that prevent full DNA replication and cause damage as a
consequence of attempted DNA synthesis.
Discussion
Many reports in the literature describe a variety of approaches
to the problem of reactivating the cell cycle in TD cells. However,
the final fate of the reactivated cells is less often described or
investigated.
Here we show that TD skeletal muscle cells subjected to CKI
RNAi do reenter the cell cycle, but cannot complete DNA
replication, suffer severe DNA damage, and die by apoptosis or as
a consequence of profoundly disrupted mitoses. In striking
contrast, reversibly quiescent fibroblasts reactivated in the same
way fully replicate their DNA, suffer no detectable damage, and in
fact proliferate even in the absence of exogenous growth factors.
We have previously shown that even permanently non-dividing,
senescent cells can be induced to replicate and proliferate by CKI
KD with no induced cell death [10]. These observations suggest
that TD myotubes are characterized by intrinsic attributes that
prevent proper DNA replication, even when induced by means
that are effective in non-TD cells.
In TD myotubes, entry into S phase is immediately followed by
accumulation of DNA damage, as best shown by significant
increases in c-H2AX early after CKI KD, when only a small
minority of the myotubes have entered S-phase (Fig. 6A). The
incompleteness of DNA replication in myotubes is another
remarkable feature of cell cycle reactivation in these cells, shown
by cytofluorimetric measurements of DNA content and partial
BrdU substitution in mitotic chromosomes. To our knowledge,
incomplete DNA replication as a characterizing feature of cell
cycle reactivation in TD cells has not been previously described.
The likely occurrence of DNA damage in reactivated TD cells has
been reported before, as activation of the DNA damage response
(DDR) [14,16]. Here, using the comet assay, we show directly
DNA fragmentation and correlate it with incomplete DNA
synthesis.
Figure 5. Myotubes reactivated by CKI KD undergo apoptosis,
which can be delayed by forced Bcl-2 expression. (A) MSC-
derived myotubes were transfected with the indicated siRNAs and
harvested at the time points shown. The indicated proteins were
analyzed by western blotting. GAPDH was used as a loading control. (B)
MSC-derived myotubes were transfected with siRNAs to p21 and p27
and mock-treated (mock) or infected with an empty adenoviral vector
or a Bcl-2-carrying virus at the indicated multiplicities of infection. The
myotubes were continuously incubated with BrdU until fixation,
48 hours later. BrdU incorporation was detected by immunofluores-
cence and nuclei were counterstained with Hoechs 33258. The
percentages of BrdU-positive (BrdU+) and mitotic or micronucleated
myotubes (mitoses) are shown. Casp = caspase; cl. = cleaved; moi =
multiplicity of infection.
doi:10.1371/journal.pone.0011559.g005
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cause or the effect of partial DNA replication. On one hand, it is
possible that chromosomal damage, possibly resulting from
attempted replication in an unpermissive cellular environment,
could bring about S-phase checkpoint activation and consequent
slow-down/arrest of DNA replication [28,29]. Alternatively, slow
DNA replication might be intrinsic to myotubes, due for example
to unique chromatin organization, and the attempt to push
replication through structural obstacles might result in DNA
damage.
Irrespective of its primary cause, DNA damage triggers
apoptosis, to which most myotubes succumb. Some of the cells,
however, enter M phase in spite of incomplete DNA replication
and heavy chromosomal damage, both of which should activate
the G2 checkpoint and prevent the onset of mitosis. However, the
reactivated myotubes have been depleted of p21, which has been
shown to be required for sustained G2 arrest [30]. Thus, myotubes
surviving apoptosis long enough enter mitosis with fragmented and
incompletely replicated DNA, resulting in mitotic catastrophe.
Accordingly, prevention of apoptosis by expression of Bcl-2 brings
a far higher number of myotubes into mitosis (Fig. 5B).
A review of the literature concerning reactivation of the cell
cycle in a variety of TD cells shows that, in most or possibly all
instances, such cells undergo either death or indefinite growth
arrest. In particular, cell death follows reactivation of myotubes
with Large T antigen [20], E1A [31], or CKI KD. Inner-ear cells
triggered to reenter the cell cycle by HPV E7 expression also die
[16]. Examples of indefinite proliferation arrest in G2 phase
include cardiomyocytes reactivated by the expression of E1A,
E2F1 [12], or Notch2 intracellular domain [14]. Interestingly,
although myotubes die in response to, e.g., CKI KD, they arrest in
G2 phase when reactivated by overexpression of cyclin D1 and
cdk4 [9]. This indicates that the specific outcome of reactivation is
dictated not only by the cell type considered, but also by the
method used to achieve cell cycle reentry.
We propose a unifying model, applicable to most TD cells, that
reconciles these two apparently divergent outcomes. We submit
that a wide variety of TD cells are intrinsically unable to effect
complete DNA replication. Thus, attempts to force these cells to
divide bring about extensive DNA damage, which can determine
different, non mutually exclusive end results: programmed cell
death as a result of DDR activation, arrest in G2 phase if the
corresponding checkpoint is functional, or entry into a catastroph-
ic mitosis if it is not. Likely, cell-type specific variations on this
mechanism exist. For example, TD cardiomyocytes physiologically
allow a single round of DNA replication not followed by cell
division [32]. Thus, cardiac cells might have strong mechanisms
preventing them from entering mitosis even after forced DNA
replication, whence their preference for arresting in G2 phase
[12,14]. We believe that the virtue of the proposed model lies in its
focusing future efforts onto finding the specific, critical feature(s) of
TD cells, whether structural or functional, that causes DNA
damage and/or hinders completion of DNA replication upon cell
cycle reentry.
Our observations might help explain why mammalian TD cells,
e.g., myotubes, unlike homologous cells in regenerating verte-
brates, e.g., urodele amphibians, cannot contribute to tissue repair
[2]. Although muscle cells from both groups of organisms can be
reactivated, only those from regenerating species yield viable
progeny that help reconstitute tissue integrity [33].
Figure 6. Histone H2AX phosphorylation in myotubes reactivated by CKI KD. (A) MSC-derived myotubes, transfected with the indicated
siRNAs, were analyzed at the time points shown for BrdU incorporation and, by western blotting, for histone H2AX phosphorylation in serine 139,
p21, and p27. Phleomycin treatment (50 mg/ml for 5 hours) was included as a positive control. b-tubulin is a loading control. Part of the b-tubulin,
p21, and p27 western blots have been already shown in Fig. 1A. (B) MSC-derived myotubes, transfected with the indicated siRNAs, were harvested
42 hours after the transfection and analyzed for the proteins shown by western blotting. c-H2AX abundance was quantitated by densitometry (upper
graph); the percentages of BrdU-positive myotubes are shown in the lower graph. cyc = cyclin. (C) Wild-type (wt) or RbLox myotubes were
transfected with siRNAs to p21 and p27 or infected with a Cre-carrying adenovirus (Ad-Cre). The cells were fixed 30 hours after transfection or
60 hours after infection and stained for the indicated proteins. Ki67 is a proliferation marker.
doi:10.1371/journal.pone.0011559.g006
Figure 7. Phosphorylation of histone H2AX in myotubes but
not fibroblasts reactivated by different strategies. C2C12
myotubes and quiescent C3H-10T1/2 fibroblasts were infected with
cell cycle-reactivating viruses expressing either E1A (dl520) or cyclin D1
and cdk4 (D1/K4). The cells were also infected with an empty control
virus (Ctr-Ad) or mock-infected. In addition, fibroblasts were reactivated
with 10% FBS or treated with Phleomycin to provide a positive control
for DNA damage. c-H2AX was analyzed by western blotting.
Multiplicities of infection as follows. Myotubes: Ctr-Ad 400, dl520 200,
cyclin D1 60, cdk4 760. C3H-10T1/2: Ctr-Ad 300, cyclin D1 30, cdk4 300,
dl520 200. l.c. = loading control.
doi:10.1371/journal.pone.0011559.g007
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attain full, harmless reactivation of TD cells. Indeed, our efforts
focus on the discovery of such methods. However, we would like to
underscore that the dramatically different responses of TD vs.
non-TD cells to the same proliferation-activating treatments point
at a hitherto poorly recognized uniqueness of TD cells and
indicate that the TD state is intrinsically—if not absolutely—
incompatible with DNA replication. We point out that there is no
current biological explanation for the observed phenomena,
indicating that they are grounded in uncharted territory.
Materials and Methods
Cells and adenoviruses
Primary MSCs were isolated and cultured as previously
described [34]. Differentiation was induced by plating the cells
on gelatin-coated dishes (Iwaki, Tokio, Japan) and culturing them
in DMEM supplemented with 10% foetal bovine serum (FBS) for
72 hours. Rb
LoxP/LoxP (RbLox) MSC have been described [27].
These cells were cultured exactly like wild-type MSC. The mouse
C2C12 myoblast cell line [35] was cultured as previously described
[9]. Differentiation was induced by plating the cells in collagen-
coated dishes (Iwaki) and culturing them in DMEM supplemented
with 5 ng/ml human insulin, 5 ng/ml human holo-transferrin and
1 mM dexamethasone for three days. To eliminate undifferenti-
ated cells, 50 mM cytosine-D-arabinofuranoside was added for the
first 48 hours only where stated. C2Q16 cells are a previously
described subclone of C2C12 cells [36], characterized by slower
but more efficient differentiation, compared to the parental cells.
C2Q16 cells were cultured and induced to differentiate exactly like
C2C12 myoblasts. Murine C3H-10T1/2 fibroblasts were cultured
in DMEM supplemented with 10% FBS and brought into
quiescence by culturing them for at least 48 hours in DMEM
containing 0.1% FBS.
The dl520 virus is a deletion mutant of type 5 human
adenovirus expressing 12S, but not 13S, E1A [9]. This virus was
used at multiplicity of infection (MOI) 70, 150, or 200. The Bcl-2
recombinant adenovirus was generated using the Ad-Easy system
[37]. Briefly, a human Bcl-2 cDNA was cloned into the pAd-track-
CMV shuttle vector. This vector and the pAd-Easy backbone were
cotransfected into 293 cells and the resulting recombinant viruses
were plaque-purifed and amplified in 293 cells. Overexpression of
human Bcl-2 was obtained by infecting myotubes at MOI 10 or
30. The E1-deleted J-pCA13 virus [38] was used as a negative
control.
RNAi experiments and siRNAs
Downregulation of target genes in C2C12 and MSC myotubes
was achieved by RNAi as already described [10]. Briefly, the
HiPerFect reagent (QIAGEN, Hilden, Germany) was used to
complex single or multiple siRNAs and transfection complexes
were kept in the culture medium (DMEM supplemented with 10%
or 5% FBS for MSCs or C2C12, respectively) until the end of the
experiments. When requested, adenoviral infection was performed
1 hours before the RNAi procedure.
siGenome individual duplex siRNAs (Dharmacon, Colorado,
USA) were used to interfere with the following mouse tran-
scripts: CDKN1A (p21, 59-GAACAGGUCGGACAUCACCUU);
CCND3 (cyclin D3, 59-AAUCACGGCAGCCAGGUCCUU);
CDKN1B (p27, 59-UAUCCCGGCAGUGCUUCUCUU). si-
Genome SMARTpool siRNA reagents (Dharmacon) were used
to interfere with DNA polymerase a RNA. SASI duplex siRNAs
(Sigma-Aldrich, St. Louis, MO, USA) were used to interfere with
murine cyclin A (59-AAUACUAGGUGCUCCAUUCdTdT) and
cyclin E (5-AGCCAAUCCAGAAGAACUGdTdT). Non-Target-
ing siRNA #2 (Dharmacon) or duplex siRNA to green fluorescent
protein (59-GGCUACGUCCAGGAGCGCACC, MWG, Ebers-
berg, Germany) were transfected as controls.
Immunofluorescence and cytofluorimetry
For immunofluorescence analysis, cells were fixed with 2%
formaldehyde and permeabilized in 0.25% Triton X-100/PBS.
The following monoclonal antibodies (mAbs) were used. BrdU:
Bu20a clone (DAKO, Glostrup, Denmark); myosin heavy chain:
MF20 [39]; c-H2AX (cat. 07-164; Millipore, Bllerica, MA, USA).
AlexaFluor-conjugated antisera to mouse IgG were obtained from
Invitrogen (San Diego, CA, USA). Nuclei were counterstained
with Hoechst 33258.
Cell cycle analyses was performed with nuclei isolated from
MSC-derived myotubes. Myotubes were incubated in 10 mM
Hepes, pH 7, 10 mM KCl, 0.1 mM EDTA, 0.1 mM EGTA for
1 hour on ice. NP-40 was added at a final concentration of 0.6%
and the cell suspension was vigorously vortexed for 30 seconds.
After a brief centrifugation, the nuclear pellet was washed with
PBS, fixed in methanol:acetone 4:1, and stained in 50 mg/ml
propidium iodide, 200 mg/ml RNAse A, 0.2% Tween 20. An
FACS Canto cytofluorimeter (Becton Dickinson) was used to
analyze the samples.
Single cell gel electrophoresis (comet assay)
Alkaline single cell gel electrophoresis was performed as
described [40]. Briefly, cell suspensions were mixed with 0,5%
low melting point agarose/PBS (BioRad, Hercules, CA, USA) and
applied to glass microscope slides coated with 1% low melting
point agarose. The gel was allowed to solidify at 4uC, then the
slides were submerged in lysis solution (2.5 M NaCl, 100 mM
EDTA, 10 mM Tris, 1% Triton X-100 and 10% DMSO, pH 10)
and kept at 4uC over night. The slides were then incubated for 20
minutes in alkaline buffer (300 mM NaOH, 1 mM EDTA,
pH 13). Electrophoresis was performed in alkaline buffer at
300 mA for 30 minutes at room temperature. After electropho-
resis, the slides were placed in neutralization buffer (0.4 M Tris-
NaOH, pH 7.5) for 5 minutes and then fixed in cold 100%
ethanol for 5 minutes. Slides were air dried and stained with
ethidium bromide, 20 mg/ml in water.
Comet images were analyzed using the IAS 2000 7.0 software
(Delta Sistemi, Roma, Italy). At least 50 nuclei per experimental
point were analyzed. The tail moment parameter is calculated as
(percentage DNA in the tail) 6(head-to-tail distance). Nuclei with
apoptotic morphology (very small comet head and extremely large
tail) were excluded from analysis.
Total cell extracts, chromatin isolation, and Western blots
To prepare total cell extracts, cells were harvested, washed in
PBS, and lysed with RIPA buffer. Chromatin extracts were
prepared following a previously published method [41], with
minor modifications. Briefly, cells were resuspended in buffer A
(10 mM Hepes, pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 0.34 M
sucrose, 10% glycerol, 0.5 mM EGTA, 0.1% Triton X-100,
0.5 mM PMSF, 1 mM DTT, 1 mM ATP, protease inhibitor
cocktail (Roche, Basel, Switzerland) and incubated 10 minutes on
ice. Nuclear pellet 1 (P1) and supernatant 1 (S1) were separated by
low-speed centrifugation. S1 was further centrifuged at high speed
to separate cytoplasmic soluble proteins (S2) from debris (P2). P1
nuclei were washed once with buffer A and then lysed in buffer B
(3 mM EDTA, 0.5 mM EGTA, 0.5 mM PMSF, 1 mM DTT,
1 mM ATP, protease inhibitor cocktail) for 30 minutes on ice.
Nuclear soluble proteins (S3) and insoluble chromatin-bound
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fractions were resuspended in Laemmli buffer and briefly
sonicated.
Proteins were separated on gradient, 4–12% polyacrylamide
gels and analyzed by western blotting with the following mAbs or
polyclonal antibodies (pAbs): mAbs to c-H2AX (Millipore), PARP-
1 (Becton Dickinson, Franklin Lakes, NJ, USA), caspase-9 (Cell
Signaling, Danvers, MA, USA), cyclin D1, GAPDH, cdc6, PCNA
(PC10) from Santa Cruz Biotechnology, Santa Cruz, CA, USA;
p27 (610241) from Becton Dickinson Transduction Laboratories);
b-tubulin (Sigma-Aldrich), NP-95 (a kind gift of I.M. Bonapace),
and Ligase 1 [42]; pAbs to mouse Apaf-1 (Millipore), caspase-3
(Cell Signaling), cdk4 (Ab-5) from NeoMarkers, Thermo, Wal-
tham, MA, USA; cdc7, p21, cyclin D3, cdk2, cdk6, cyclin A, cyclin
E, and MCM-2 (sc-9839) from Santa Cruz Biotechnology.
Peroxidase-conjugated antisera to mouse and rabbit IgG were
from Bio-Rad Laboratories. Western blots were revealed using the
SuperSignal kit (Pierce Chemical Co., Rockford, IL, USA).
Supporting Information
Figure S1 Centrosome and mitotic spindle detection in
reactivated miotubes. MSC-derived myotubes reactivated by
CKI KD and proliferating MSC were immunostained for the
centrosome marker c-tubulin (A) or the microtubule constituent b-
tubulin (B). Nuclei were counterstained with Hoechst 33258.
Found at: doi:10.1371/journal.pone.0011559.s001 (1.26 MB TIF)
Figure S2 Single-CKI KD does not elicit DNA damage. MSC-
derived myotubes were transfected with siRNAs to p21, p27, or
both. The cells were fixed 30 hours later, immunostained for the
indicated proteins, and countestained with Hoechst 33258.
Found at: doi:10.1371/journal.pone.0011559.s002 (1.01 MB TIF)
Figure S3 DNA replication machinery in CKI KD-reactivated
myotubes. (A) MSC-derived myotubes were transfected or infected
as shown and the indicated proteins were analyzed by western
blotting at successive time points. Proliferating MSC are included
for reference. (B) MSC-derived myotubes were transfected as
shown and the indicated proteins were analyzed by western
blotting at successive time points. the graph reports the
percentages of BrdU-positive cells at successive time points. (C)
MSC-derived myotubes were transfected as indicated and
compared with quiescent or serum-stimulated C3H-10T1/2 cells.
Total cell extracts were fractionated into soluble cytoplasmic (S2),
soluble nuclear (S3), and chromatin (P3) fractions and analyzed for
the indicated proteins by western blotting 30 hours later. Whole
cell lysates (WCL) from myotubes (Mt) and MSC are included for
reference. The percentages of BrdU-positive cells are shown in the
bottom table.
Found at: doi:10.1371/journal.pone.0011559.s003 (1.36 MB TIF)
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